IBSA: Innovative solutions for the pharmaceutical market

Thanks to its consolidated experience, industrial capacity and proprietary technologies, IBSA provides comprehensive services from drug development to drug manufacturing for EU and non-EU markets.

IBSA’s Research & Development activities employ latest-generation technologies to optimise the bioavailability, efficacy and safety of existing active substances in order to develop simpler, more evolved treatment systems.

Read the Whole Article

Related Articles

+

05.03.2024

OSTEOARTHRITIS AND VISCOSUPPLEMENTATION – Advertorial – Chemistry today

Osteoarthritis, the most common cause of musculoskeletal disability. Let’s find out more with the IBSA NAHYCO® HYBRID TECHNOLOGY.

+

05.03.2024

OSTEOARTHRITIS AND VISCOSUPPLEMENTATION – Advertorial – Chemistry today

Osteoarthritis, the most common cause of musculoskeletal disability. Let’s find out more with the IBSA NAHYCO® HYBRID TECHNOLOGY.

+

31.10.2023

A word with Andrea Taborelli – Interview with Chimica Oggi – Chemistry Today

Andrea Toborelli, Business Development and Licensing Manager at IBSA, was interview by Nutra Horizons.